Your search returned 3 results.

Results
	1.	Pharmacokinetic/pharmacodynamic-based decision making in the development of MK-0888, a VEGFR-2/FLT-3 kinase inhibitor. [electronic resource] by Iwamoto, Marian Friedman, Evan J Sepp-Lorenzino, Laura Talaty, Jennifer E Agrawal, Nancy G B Wagner, John A Producer: 20150331 In: Cancer chemotherapy and pharmacology vol. 75 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Disposition and metabolism of the cathepsin K inhibitor odanacatib in humans. [electronic resource] by Kassahun, Kelem McIntosh, Ian Koeplinger, Kenneth Sun, Li Talaty, Jennifer E Miller, Deborah L Dixon, Russell Zajic, Stefan Stoch, S Aubrey Producer: 20141125 In: Drug metabolism and disposition: the biological fate of chemicals vol. 42 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	3.	Assessment of Drug Interaction Potential Between the Hepatitis C Virus Direct-Acting Antiviral Agents Elbasvir/Grazoprevir and the Nucleotide Analog Reverse-Transcriptase Inhibitor Tenofovir Disoproxil Fumarate. [electronic resource] by Feng, Hwa-Ping Guo, Zifang Caro, Luzelena Talaty, Jennifer E Mangin, Eric Panebianco, Deborah Fandozzi, Christine Zhu, Yali Marshall, William Huang, Xiaobi Hanley, William D Jumes, Patricia Valesky, Robert Martinho, Monika Butterton, Joan R Iwamoto, Marian Yeh, Wendy W Producer: 20200804 In: Clinical pharmacology in drug development vol. 8 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)